Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Response Biomed Corp RPBIF

"Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets."


GREY:RPBIF - Post by User

Bullboard Posts
Comment by HippygirL74on May 08, 2009 7:09pm
328 Views
Post# 15979880

RE: RE: we know our pps won't go lower then 15

RE: RE: we know our pps won't go lower then 15MDbioguy,

Maybe 3M should have consulted with you first before launching or attempting to launch their FluA and FluB test.  Why don't you tell them to cancel all efforts with the RSV test too.  You don't think revenues from New Zealand or Australia or SouthEast Asia means anything?  Or even South America?  

As for cardiac not becoming an accepted test, tell that to Roche and ask why they are updating the new Troponin I test to correlate with Roches own lab based test.   And if you are correct, then why has Roche applied for CLIA waiver?

Sounds like you sold to me.  Time to load up instead.  
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse